Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer’s Disease Brain
Sravani Musunuri(Uppsala University), Kim Kultima(Uppsala University), Lars Lannfelt(BioArctic Neuroscience (Sweden)), Anna Månberg(Science for Life Laboratory), Ganna Shevchenko(Uppsala University), Anna Erlandsson(Uppsala University), Jonas Bergquist(Uppsala University), Payam Emami Khoonsari(Stockholm University), Peter Nilsson(Science for Life Laboratory), Martin Ingelsson(Uppsala University), Magnus Wetterhall(Uppsala University), Maria Mikus(Science for Life Laboratory)
Cited by 32
Related Papers
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
|Neurology|2004|655
High levels of AAV vector integration into CRISPR-induced DNA breaks
|Nature Communications|2019|430